This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Drugs, sex, money and power: An HPV vaccine case study

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Haas, Marion
Ashton, Toni
Blum, Kerstin
Christiansen, Terkel
Conis, Elena
Crivelli, Luca
Lim, Meng Kin
Lisac, Melanie
MacAdam, Margaret
Schlette, Sophia

Additional information is available for the following registered author(s):

Abstract

In this paper we compare the experiences of seven industrialized countries in considering approval and introduction of the world's first cervical cancer-preventing vaccine. Based on case studies, articles from public agencies, professional journals and newspapers we analyse the public debate about the vaccine, examine positions of stakeholder groups and their influence on the course and outcome of this policy process. The analysis shows that the countries considered here approved the vaccine and established related immunization programs exceptionally quickly even though there still exist many uncertainties as to the vaccine's long-term effectiveness, cost-effectiveness and safety. Some countries even bypassed established decision-making processes. The voice of special interest groups has been prominent in all countries, drawing on societal values and fears of the public. Even though positions differed among countries, all seven decided to publicly fund the vaccine, illustrating a widespread convergence of interests. It is important that decision-makers adhere to transparent and robust guidelines in making funding decisions in the future to avoid capture by vested interests and potentially negative effects on access and equity.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.sciencedirect.com/science/article/B6V8X-4WG79JH-2/2/67fb631119105447875c1fb5928524cc
File Format:
File Function:
Download Restriction: Full text for ScienceDirect subscribers only

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Elsevier in its journal Health Policy.

Volume (Year): 92 (2009)
Issue (Month): 2-3 (October)
Pages: 288-295
Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Handle: RePEc:eee:hepoli:v:92:y:2009:i:2-3:p:288-295

Contact details of provider:
Web page: http://www.elsevier.com/locate/healthpol

For technical questions regarding this item, or to correct its listing, contact: (Heidi Boesdal) or ().

Related research
Keywords: Vaccination Human Papillomavirus Decision making Public health Pharmaceutical policy Public policy;

Statistics
Access and download statistics

Did you know? All full texts are decentralized with the publishers, none reside on this server, thus making it possible to offer this service for free to all parties.

This page was last updated on 2009-12-30.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.